Microfluidic Technology in Cancer Treatment Current Applications and Future Potentials

Abstract

Microfluidic technology, as a powerful tool for precise manipulation of small biological samples, is reshaping the landscape of cancer diagnosis and treatment and has become a core driving force for advancing personalized cancer therapy. This paper focuses on the transformative role of microfluidic technology in current cancer treatment, with a key emphasis on its applications in personalized therapy. Taking microfluidic platforms for drug testing as a typical example, the study demonstrates that these systems can leverage patient-derived tumor models to conduct high-throughput assays, thereby facilitating the optimization of individualized treatment strategies. Through the analysis of clinical application cases, it is verified that this technology can effectively shorten the duration of treatment selection, enhance prediction accuracy and reduce unnecessary drug administration. Current challenges of the technology lie in the lack of unified standards and clear translational pathways for clinical adoption, while future development directions are oriented towards the integration of artificial intelligence, the combination of multi-source datasets and the construction of point-of-care diagnostic and treatment systems. This comprehensive paper provides evidence-based insights for clinicians and researchers dedicated to translating microfluidic advances into routine clinical practice for precision cancer therapy.